Market Tracker

09/04 6:45pm ET

Galena Biopharma Inc (NASDAQ:GALE)

1.56
Delayed Data
As of Sep 04
 -0.06 / -3.70%
Today’s Change
1.10
Today|||52-Week Range
2.50
+3.31%
Year-to-Date

Today’s Trading

Previous close1.62
Today’s open1.59
Day’s range1.52 - 1.59
Volume1,161,182
Average volume (3 months)2,291,655
Market cap$252.3M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+63.53%
Earnings growth (this year)-3.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+274.71%
P/E ratioNM
Price/Sales19.35
Price/Book5.45

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp+0.04+1.98%
PPHMPeregrine Pharmaceut...+0.01+0.85%
AGTCApplied Genetic Tech...+0.07+0.43%
CRHMCRH Medical Corp+0.08+2.10%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 16, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$9.3M
Annual profit (last year)-$36.6M
Net profit margin-392.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
Portland, Oregon

Forecasts